| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Blood Donation, Payment, and Non-Cash Incentives: Classical Questions Drawing Renewed Interest.
|
2009
|
1.52
|
|
2
|
The Bloodgen Project of the European Union, 2003-2009.
|
2009
|
1.36
|
|
3
|
Cryopreservation of Human Stem Cells for Clinical Application: A Review.
|
2011
|
1.23
|
|
4
|
Physiology and pharmacology of erythropoietin.
|
2013
|
1.21
|
|
5
|
Pulmonary transfusion reactions.
|
2008
|
1.19
|
|
6
|
Quality and Safety in Blood Supply in 2010.
|
2010
|
1.17
|
|
7
|
Effects of storage of red cells.
|
2008
|
1.16
|
|
8
|
Demographic Changes: The Impact for Safe Blood Supply.
|
2010
|
1.15
|
|
9
|
Standardization of NAT for Blood-Borne Pathogens.
|
2015
|
1.12
|
|
10
|
In vitro Differentiation Potential of Mesenchymal Stem Cells.
|
2008
|
1.12
|
|
11
|
Measurement of red cell lifespan and aging.
|
2012
|
1.12
|
|
12
|
Impact of interleukin-6 in hematological malignancies.
|
2013
|
1.11
|
|
13
|
Emerging Pathogens - How Safe is Blood?
|
2013
|
1.10
|
|
14
|
Prosocial Motivation and Blood Donations: A Survey of the Empirical Literature.
|
2010
|
1.09
|
|
15
|
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.
|
2012
|
1.08
|
|
16
|
Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.
|
2013
|
1.08
|
|
17
|
Predictive Models and Algorithms for the Need of Transfusion Including Massive Transfusion in Severely Injured Patients.
|
2012
|
1.08
|
|
18
|
Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
|
2008
|
1.07
|
|
19
|
Hemolytic Transfusion Reactions.
|
2008
|
1.06
|
|
20
|
Massive Bleeding and Massive Transfusion.
|
2012
|
1.05
|
|
21
|
Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention.
|
2008
|
1.05
|
|
22
|
Report on Notifications Pursuant to section sign21 German Transfusion Act for 2007.
|
2010
|
1.05
|
|
23
|
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.
|
2011
|
1.05
|
|
24
|
Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.
|
2008
|
1.04
|
|
25
|
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™
|
2011
|
1.04
|
|
26
|
Responder individuality in red blood cell alloimmunization.
|
2014
|
1.03
|
|
27
|
The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma.
|
2011
|
1.03
|
|
28
|
Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010).
|
2011
|
1.03
|
|
29
|
Obstacles of Multiplex Real-Time PCR for Bacterial 16S rDNA: Primer Specifity and DNA Decontamination of Taq Polymerase.
|
2010
|
1.03
|
|
30
|
Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations.
|
2013
|
1.02
|
|
31
|
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.
|
2007
|
1.02
|
|
32
|
Human-derived alternatives to fetal bovine serum in cell culture.
|
2013
|
1.01
|
|
33
|
Reactions Induced by Platelet Transfusions.
|
2008
|
1.01
|
|
34
|
Donor Hemovigilance during Preparatory Plasmapheresis.
|
2014
|
1.01
|
|
35
|
Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.
|
2010
|
1.00
|
|
36
|
Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply.
|
2010
|
0.99
|
|
37
|
Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System.
|
2011
|
0.99
|
|
38
|
Organ Preservation: Current Concepts and New Strategies for the Next Decade.
|
2011
|
0.98
|
|
39
|
The Stromal Activity of Mesenchymal Stromal Cells.
|
2008
|
0.98
|
|
40
|
Demographic Changes in Germany up to 2060 - Consequences for Blood Donation.
|
2010
|
0.98
|
|
41
|
National Blood Service TRALI Reduction Policies: Implementation and Effect.
|
2008
|
0.98
|
|
42
|
Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes - Role of Redox Stress and Band 3 Modifications.
|
2012
|
0.97
|
|
43
|
Assessment of Impact of Training in Improving Knowledge of Blood Transfusion among Clinicians.
|
2014
|
0.97
|
|
44
|
Homing of Mesenchymal Stem Cells.
|
2008
|
0.97
|
|
45
|
Autochthonous hepatitis e virus infections: a new transfusion-associated risk?
|
2013
|
0.96
|
|
46
|
DGTI Register of Rare Donors.
|
2014
|
0.95
|
|
47
|
BGMUT Database of Allelic Variants of Genes Encoding Human Blood Group Antigens.
|
2014
|
0.95
|
|
48
|
The Mannheim Cord Blood Bank: Experiences and Perspectives for the Future.
|
2010
|
0.95
|
|
49
|
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.
|
2015
|
0.95
|
|
50
|
MYH-9 Related Platelet Disorders: Strategies for Management and Diagnosis.
|
2010
|
0.94
|